Detalhe da pesquisa
1.
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer.
Oncology;
102(1): 9-16, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37598677
2.
Outcomes in Premenopausal Patients with HR+/HER2- Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence Score.
Oncologist;
28(12): 1049-1054, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37682780
3.
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.
Cancer;
128(20): 3602-3609, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35947048
4.
Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer.
Breast Cancer Res Treat;
192(2): 313-319, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35006484
5.
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer.
Breast Cancer Res Treat;
189(1): 177-185, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34169393
6.
Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score.
Ann Surg Oncol;
28(11): 5941-5947, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33813671
7.
Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
Oncology;
99(5): 280-291, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33652435
8.
Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31.
Oncology;
99(11): 699-702, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34425579
9.
BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database.
Oncology;
98(4): 248-251, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31962330
10.
Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients.
Oncology;
98(8): 589-592, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32182614
11.
Prevalence of physical problems detected by the distress thermometer and problem list in patients with breast cancer.
Psychooncology;
27(5): 1394-1403, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29315955
12.
Physical Symptom Burden and Its Association With Distress, Anxiety, and Depression in Breast Cancer.
Psychosomatics;
59(5): 464-471, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29525522
13.
Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer.
Gynecol Oncol;
144(2): 279-284, 2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27931751
14.
Early Childhood Adversity and its Associations With Anxiety, Depression, and Distress in Women With Breast Cancer.
Psychosomatics;
57(2): 174-84, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26876888
15.
Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.
Breast Cancer Res;
16(2): R32, 2014 Mar 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24684785
16.
Continuous-infusion topotecan and erlotinib: a study in topotecan-pretreated ovarian cancer assessing shed collagen epitopes as a marker of invasiveness.
Oncologist;
19(3): 250, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24563078
17.
Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report.
J Dermatolog Treat;
35(1): 2336118, 2024 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38565207
18.
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.
JAMA Oncol;
10(3): 362-371, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38236590
19.
A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer.
Int J Gynecol Cancer;
23(9): 1577-82, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24172094
20.
An emerging generation of endocrine therapies in breast cancer: a clinical perspective.
NPJ Breast Cancer;
9(1): 20, 2023 Apr 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37019913